333 filings
Page 3 of 17
8-K
xxq xjdskb2kfnet
12 Jul 23
Other Events
12:00am
S-8
8p17a6v5wh2 lv8lx
20 Jun 23
Registration of securities for employees
4:01pm
S-8 POS
f1qx9u3d76zfm
20 Jun 23
Registration of securities for employees (post-effective amendment)
4:00pm
8-K
jckpie56gzs9r za8n6
1 Jun 23
Departure of Directors or Certain Officers
4:00pm
8-K
vp709ebhfkxkt rgda
12 May 23
HARNESSING THE POWER OF THE INNATE IMMUNE SYSTEM INMB Webinar Phase I/II Trial of INKmune ʳ in Metastatic Castration - Resistant Prostate Cancer
8:00am
8-K
yafzpt
8 May 23
Other Events
8:02am
8-K
mt6nxxeepjhrlswlw
4 May 23
INmune Bio Inc. Announces First Quarter 2023 Results and Provides Business Update
4:00pm
8-K
g4afj cycfil
24 Apr 23
INmune Bio, Inc. to Report First Quarter 2023 Financial Results and Provide a Corporate Update on Wednesday, May 3
4:00pm
8-K
m71g gcdkjo41mpzmmxf
20 Apr 23
XPro1595 Improves Outcomes in a Mouse Model of TBI-induced Alzheimer’s Disease
4:30pm
8-K
deaw 0m5hf6q
11 Apr 23
Other Events
4:00pm
UPLOAD
xuxu6u3olf18d9yn be
10 Apr 23
Letter from SEC
12:00am
8-K
hppy i5owa0ek1tnuz5
3 Apr 23
Other Events
9:12am
CORRESP
lu5x fotwn
31 Mar 23
Correspondence with SEC
12:00am
UPLOAD
ih7cxco6 2zo
28 Mar 23
Letter from SEC
12:00am
8-K
76g3d1uyaii 492jht4r
15 Mar 23
Other Events
4:00pm
8-K
15z064
3 Mar 23
INmune Bio, Inc. Announces 2022 Results and Provides Business Update
4:47pm
8-K
srkdk66n6mjs2g xfq
22 Feb 23
Other Events
4:00pm